日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Taiwan liver cancer association management consensus guidelines for intermediate-stage hepatocellular carcinoma

台湾肝癌协会中期肝细胞癌管理共识指南

Lee, I-Cheng; Wang, Hung-Wei; Teng, Wei; Lin, Tsung-Jung; Chen, Chien-Hung; Lai, Hsueh-Chou; Lee, Teng-Yu; Chang, Ching-Wei; Hung, Chao-Hung; Dai, Chia-Yen; Hung, Yi-Ping; Shen, Ying-Chun; Su, Chien-Wei; Ho, Ming-Chih; Lee, Wei-Chen; Chau, Gar-Yang; Ting, Chin-Tsung; Liang, Po-Chin; Liu, Chien-An; Chang, Pi-Yi; Chen, Kuan-Yang; Lin, Shi-Ming; Chen, Li-Tzong; Huang, Yi-Hsiang

An integrated language-vision foundation model for conversational diagnostics and triaging in primary eye care

一种用于初级眼科护理中对话诊断和分诊的综合语言-视觉基础模型

Soh, Zhi Da; Bai, Yang; Yu, Kai; Zhou, Yang; Lei, Xiaofeng; Thakur, Sahil; Lee, Zann; Phang, Lee Ching Linette; Peng, Qingsheng; Xue, Can Can; Chong, Rachel Shujuan; Hoang, Quan V; Raghavan, Lavanya; Tham, Yih Chung; Sabanayagam, Charumathi; Wu, Wei-Chi; Ho, Ming-Chih; He, Jiangnan; Gupta, Preeti; Lamoureux, Ecosse; Saw, Seang Mei; Nangia, Vinay; Panda-Jonas, Songhomitra; Xu, Jie; Wang, Ya Xing; Xu, Xinxing; Jonas, Jost B; Wong, Tien Yin; Goh, Rick Siow Mong; Liu, Yong; Cheng, Ching-Yu

Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trial

对患有慢性活动性乙型肝炎且无法切除的肝细胞癌患者,及时启动度伐利尤单抗和曲美利木单抗治疗:一项 II 期临床试验

Shao, Yu-Yun; Chen, Ching-Tso; Chuang, Chien-Huai; Su, Tung-Hung; Ho, Ming-Chih; Tseng, Tai-Chung; Liu, Tsung-Hao; Wu, Tsung-Che; Cheng, Ann-Lii; Hsu, Chih-Hung

Sequential combination with ropeginterferon alfa-2b and anti-PD-1 treatment as adjuvant therapy in HBV-related HCC: a phase 1 dose escalation trial

罗培干扰素α-2b联合抗PD-1治疗作为乙型肝炎病毒相关肝细胞癌辅助治疗:一项1期剂量递增试验

Qin, Albert; Ho, Ming-Chih; Tsai, Chan-Yen; Liu, Chun-Jen; Chen, Pei-Jer

HBV DNA Integration into Telomerase or MLL4 Genes and TERT Promoter Point Mutation as Three Independent Signatures in Subgrouping HBV-Related HCC with Distinct Features

HBV DNA整合到端粒酶或MLL4基因以及TERT启动子点突变是HBV相关肝细胞癌亚组划分中三个独立的特征标志。

Li, Chiao-Ling; Hsu, Chia-Lang; Lin, You-Yu; Ho, Ming-Chih; Hu, Ray-Heng; Chen, Chi-Ling; Ho, Tung-Ching; Lin, Yung-Feng; Tsai, Shih-Feng; Tzeng, Sheng-Tai; Huang, Chin-Fang; Wang, Ya-Chun; Yeh, Shiou-Hwei; Chen, Pei-Jer

PB1885: PHASE 1 STUDY OF ZIFTOMENIB IN COMBINATION WITH VENETOCLAX, VENETOCLAX/AZACITIDINE, OR STANDARD INDUCTION (7 + 3) CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

PB1885:齐夫托米尼联合维奈托克、维奈托克/阿扎胞苷或标准诱导(7+3)化疗治疗急性髓系白血病患者的I期研究

Yeh, Shiou-Hwei; Li, Chiao-Ling; Lin, You-Yu; Ho, Ming-Chih; Wang, Ya-Chun; Tseng, Sheng-Tai; Chen, Pei-Jer; Zeidan, Amer M; Fathi, Amir; Issa, Ghayas; Erba, Harry; Mackey, Julie Ahsan; Corum, Daniel; Tomkinson, Blake; Kozlek, Tom; Leoni, Mollie; Wang, Eunice

Sequential Therapy with Ropeginterferon Alfa-2b and Anti-Programmed Cell Death 1 Antibody for Inhibiting the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results

采用罗培干扰素α-2b和抗程序性细胞死亡蛋白1抗体进行序贯治疗以抑制乙型肝炎相关肝细胞癌的复发:从动物模型到I期临床试验结果

Qin, Albert; Wu, Chang-Ru; Ho, Ming-Chih; Tsai, Chan-Yen; Chen, Pei-Jer

A pilot study for the prediction of liver function related scores using breath biomarkers and machine learning

利用呼吸生物标志物和机器学习预测肝功能相关评分的初步研究

Patnaik, Rakesh Kumar; Lin, Yu-Chen; Agarwal, Ashish; Ho, Ming-Chih; Yeh, J Andrew

Delayed Hepatocellular Carcinoma Recurrence After Liver Transplantation: Comprehensive Clinical Characterization of Case Series

肝移植术后肝细胞癌延迟复发:病例系列的全面临床特征分析

Wong, Ta-Hsiang; Ho, Cheng-Maw; Hsu, Hsao-Hsun; Wu, Yao-Ming; Ho, Ming-Chih; Lee, Po-Huang; Hu, Rey-Heng

Different clinical and genetic features of Alagille patients with progressive disease versus a jaundice-free course

Alagille 病患者在临床和遗传特征上存在差异,其中进展型患者与无黄疸型患者存在不同的临床和遗传特征。

Chiang, Che-Ming; Jeng, Yung-Ming; Ho, Ming-Chih; Lai, Ming-Wei; Li, Huei-Ying; Chen, Pei-Lung; Lee, Ni-Chung; Wu, Jia-Feng; Chiu, Yu-Chun; Liou, Bang-Yu; Ni, Yen-Hsuan; Hsu, Hong-Yuan; Chang, Mei-Hwei; Chen, Huey-Ling